BLGO - BIOLARGO, INC.
0.1644
0.000 -0.061%
Share volume: 188,103
Last Updated: 03-26-2026
Chemicals/Chemicals And Allied Products:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.16
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | 03-04-2026 | |
| Assets | ||||||||
| Total Assets | 9.821 M | 10.053 M | 10.305 M | 10.511 M | 12.499 M | 9.130 M | 8.311 M | |
| Current Assets | 7.176 M | 7.110 M | 7.394 M | 7.218 M | 9.187 M | 5.775 M | 5.114 M | |
| Inventories | 251.000 K | 176.000 K | 238.000 K | 369.000 K | 444.000 K | 409.000 K | 310.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 5.221 M | 0.000 | 0.000 | |
| Current Cash | 4.336 M | 4.765 M | 3.882 M | 2.564 M | 3.471 M | 4.546 M | 3.883 M | |
| Total Non-current Assets | 18.000 K | 18.000 K | 15.000 K | 16.000 K | 23.000 K | 23.000 K | 0.000 | |
| Property Plant Equipment | 1.489 M | 1.811 M | 1.807 M | 1.700 M | 1.664 M | 1.664 M | 1.643 M | |
| Other Assets | 1.156 M | 1.132 M | 1.104 M | 1.593 M | 1.648 M | 1.691 M | 1.472 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 9.821 M | 10.053 M | 10.305 M | 10.511 M | 12.499 M | 9.130 M | 8.311 M | |
| Total liabilities | 4.673 M | 4.161 M | 4.324 M | 5.421 M | 6.439 M | 5.915 M | 6.785 M | |
| Total current liabilities | 3.404 M | 3.012 M | 3.200 M | 3.373 M | 4.080 M | 3.451 M | 5.063 M | |
| Accounts Payable | 1.740 M | 3.943 M | 4.400 M | 3.514 M | 4.043 M | 2.916 M | 2.803 M | |
| Other liabilities | 985.000 K | 0.000 | 0.000 | 339.000 K | 317.000 K | 295.000 K | 864.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 284.000 K | 184.000 K | 180.000 K | 812.000 K | 1.170 M | 1.200 M | 601.000 K | |
| Other liabilities | 985.000 K | 0.000 | 0.000 | 339.000 K | 317.000 K | 295.000 K | 864.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.115 M | 6.002 M | 8.577 M | 7.609 M | 8.755 M | 6.580 M | 4.042 M | |
| Common stock | 155.804 M | 154.193 M | 157.293 M | 158.467 M | 160.806 M | 165.102 M | 165.529 M | |
| Retained earnings | -147.508 M | -147.949 M | -148.486 M | -150.655 M | -151.848 M | -158.327 M | -161.280 M |